SV2002000290A - Eteres de dicarboxilato de calcio, metodos para su preparacion y tratamiento de las enfermedades vasculares y diabetes con los mismos ref. pc5953-01-ca/20132/bb - Google Patents

Eteres de dicarboxilato de calcio, metodos para su preparacion y tratamiento de las enfermedades vasculares y diabetes con los mismos ref. pc5953-01-ca/20132/bb

Info

Publication number
SV2002000290A
SV2002000290A SV2001000290A SV2001000290A SV2002000290A SV 2002000290 A SV2002000290 A SV 2002000290A SV 2001000290 A SV2001000290 A SV 2001000290A SV 2001000290 A SV2001000290 A SV 2001000290A SV 2002000290 A SV2002000290 A SV 2002000290A
Authority
SV
El Salvador
Prior art keywords
eteres
diabetes
preparation
treatment
methods
Prior art date
Application number
SV2001000290A
Other languages
English (en)
Spanish (es)
Inventor
Donald Eugene Butler
Gary Jay Dozeman
Howard Yoshihisa Ando
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of SV2002000290A publication Critical patent/SV2002000290A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/125Saturated compounds having only one carboxyl group and containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235Saturated compounds containing more than one carboxyl group
    • C07C59/305Saturated compounds containing more than one carboxyl group containing ether groups, groups, groups, or groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
SV2001000290A 2000-01-25 2001-01-22 Eteres de dicarboxilato de calcio, metodos para su preparacion y tratamiento de las enfermedades vasculares y diabetes con los mismos ref. pc5953-01-ca/20132/bb SV2002000290A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17782300P 2000-01-25 2000-01-25

Publications (1)

Publication Number Publication Date
SV2002000290A true SV2002000290A (es) 2002-07-16

Family

ID=22650106

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2001000290A SV2002000290A (es) 2000-01-25 2001-01-22 Eteres de dicarboxilato de calcio, metodos para su preparacion y tratamiento de las enfermedades vasculares y diabetes con los mismos ref. pc5953-01-ca/20132/bb

Country Status (39)

Country Link
EP (1) EP1259474B1 (cg-RX-API-DMAC7.html)
JP (1) JP4750995B2 (cg-RX-API-DMAC7.html)
KR (1) KR20020073182A (cg-RX-API-DMAC7.html)
CN (1) CN1395555A (cg-RX-API-DMAC7.html)
AP (1) AP2002002587A0 (cg-RX-API-DMAC7.html)
AR (1) AR029436A1 (cg-RX-API-DMAC7.html)
AT (1) ATE431326T1 (cg-RX-API-DMAC7.html)
AU (1) AU2214001A (cg-RX-API-DMAC7.html)
BG (1) BG106851A (cg-RX-API-DMAC7.html)
BR (1) BR0107763A (cg-RX-API-DMAC7.html)
CA (1) CA2397960C (cg-RX-API-DMAC7.html)
CO (1) CO5261537A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ20022474A3 (cg-RX-API-DMAC7.html)
DE (1) DE60138686D1 (cg-RX-API-DMAC7.html)
DK (1) DK1259474T3 (cg-RX-API-DMAC7.html)
DZ (1) DZ3239A1 (cg-RX-API-DMAC7.html)
EA (1) EA004862B1 (cg-RX-API-DMAC7.html)
EE (1) EE200200404A (cg-RX-API-DMAC7.html)
ES (1) ES2324281T3 (cg-RX-API-DMAC7.html)
GE (1) GEP20053428B (cg-RX-API-DMAC7.html)
GT (1) GT200100015A (cg-RX-API-DMAC7.html)
HN (1) HN2001000011A (cg-RX-API-DMAC7.html)
HU (1) HUP0204422A3 (cg-RX-API-DMAC7.html)
IL (1) IL150541A0 (cg-RX-API-DMAC7.html)
IS (1) IS6442A (cg-RX-API-DMAC7.html)
MA (1) MA26867A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA02007223A (cg-RX-API-DMAC7.html)
NO (1) NO20023526L (cg-RX-API-DMAC7.html)
NZ (1) NZ519550A (cg-RX-API-DMAC7.html)
OA (1) OA12166A (cg-RX-API-DMAC7.html)
PA (1) PA8510601A1 (cg-RX-API-DMAC7.html)
PE (1) PE20011064A1 (cg-RX-API-DMAC7.html)
PL (1) PL357076A1 (cg-RX-API-DMAC7.html)
SK (1) SK10622002A3 (cg-RX-API-DMAC7.html)
SV (1) SV2002000290A (cg-RX-API-DMAC7.html)
TN (1) TNSN01013A1 (cg-RX-API-DMAC7.html)
UY (1) UY26550A1 (cg-RX-API-DMAC7.html)
WO (1) WO2001055078A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200205880B (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1481962A1 (en) * 1997-12-12 2004-12-01 Warner-Lambert Company LLC New cholesterolemia-lowering carboxyalkylether compound
KR20050058454A (ko) * 2002-08-22 2005-06-16 워너-램버트 캄파니 엘엘씨 골관절염의 치료 방법
CA2605331A1 (en) * 2005-04-19 2006-11-02 Eisai R & D Management Co., Ltd. Calcium bis[(2s)-3-[3-[(2s)-3-(4-chloro-2-cyanophenoxy)-2- fluoropropoxy]phenyl]-2-isopropoxypropionate] and intermediate thereof
US7816405B2 (en) 2005-04-19 2010-10-19 Eisai R&D Management Co., Ltd. Calcium bis [(2S)-3-[3-[(2S)-3-(4-chloro-2-cyanophenoxy)-2-fluoropropoxy]phenyl ]-2-isopropoxypropionate] and intermediate thereof
WO2016077832A2 (en) * 2014-11-14 2016-05-19 Gemphire Therapeutics Inc. PROCESSES AND INTERMEDIATES FOR PREPARING α,ω-DICARBOXYLIC ACID-TERMINATED DIALKANE ETHERS
CA3059073A1 (en) * 2017-04-18 2018-10-25 Daniela Carmen Oniciu Gemcabene, pharmaceutically acceptable salts thereof, compositions thereof and methods of use therefor
EP3867222A4 (en) * 2018-10-18 2022-07-06 Gemphire Therapeutics Inc. GEMCABENE, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, COMPOSITIONS THEREOF, AND METHODS OF USE THEREOF

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648387A (en) 1995-03-24 1997-07-15 Warner-Lambert Company Carboxyalkylethers, formulations, and treatment of vascular diseases
NZ503982A (en) 1997-12-12 2002-03-28 Warner Lambert Co Statin-carboxyalkylether combinations useful for treating vascular disorders and diabetes mellitus

Also Published As

Publication number Publication date
CN1395555A (zh) 2003-02-05
HN2001000011A (es) 2001-06-13
EP1259474B1 (en) 2009-05-13
CO5261537A1 (es) 2003-03-31
IL150541A0 (en) 2003-02-12
CA2397960A1 (en) 2001-08-02
OA12166A (en) 2003-11-07
JP2003520835A (ja) 2003-07-08
NO20023526D0 (no) 2002-07-24
UY26550A1 (es) 2001-08-27
PE20011064A1 (es) 2001-10-22
TNSN01013A1 (fr) 2005-11-10
EE200200404A (et) 2003-10-15
ATE431326T1 (de) 2009-05-15
ZA200205880B (en) 2003-07-23
MXPA02007223A (es) 2002-11-29
DE60138686D1 (de) 2009-06-25
NZ519550A (en) 2003-11-28
MA26867A1 (fr) 2004-12-20
GT200100015A (es) 2001-10-19
CZ20022474A3 (cs) 2003-06-18
AP2002002587A0 (en) 2002-09-30
SK10622002A3 (sk) 2003-07-01
NO20023526L (no) 2002-08-27
IS6442A (is) 2002-06-25
CA2397960C (en) 2008-09-09
PA8510601A1 (es) 2002-08-26
EA200200641A1 (ru) 2002-12-26
ES2324281T3 (es) 2009-08-04
HUP0204422A3 (en) 2003-08-28
WO2001055078A1 (en) 2001-08-02
DZ3239A1 (fr) 2001-08-02
HUP0204422A2 (en) 2003-05-28
KR20020073182A (ko) 2002-09-19
JP4750995B2 (ja) 2011-08-17
EA004862B1 (ru) 2004-08-26
BG106851A (en) 2003-01-31
PL357076A1 (en) 2004-07-12
AU2214001A (en) 2001-08-07
AR029436A1 (es) 2003-06-25
BR0107763A (pt) 2002-11-12
DK1259474T3 (da) 2009-07-20
GEP20053428B (en) 2005-01-25
EP1259474A1 (en) 2002-11-27

Similar Documents

Publication Publication Date Title
ES2054501T3 (es) Procedimiento para la fabricacion de ramnosa a partir de ramnolipidos.
DE60025369D1 (de) Unterchlorige säure enthaltendes superoxidiertes wasser zur behandlung von wunden
ATE343388T1 (de) Pde-v hemmer zur behandlung von morbus parkinson
ES2119124T3 (es) Bencimidazoles utiles para el tratamiento de trastornos del sistema nervioso.
AR041932A1 (es) Derivados de ciclohexano espirociclicos, preparacion de los mismos, su uso en la fabricacion de medicamentos y dichos medicamentos.
ATE268179T1 (de) Verwendung von substituierten imidazo (1,2- a)pyridin-, -pyrimidin- und -pyrazin-3-yl-amin- derivaten zur herstellung von medikamenten zur nos-inhibierung
ES2162942T3 (es) Nuevos derivados de acidos carboxilicos, su obtencion y empleo.
DE69328474D1 (de) Verwendung von substituierten Adeninderivaten zur Behandlung von MultipleSklerose
DK0585026T3 (da) Anvendelse af fedtsyrer til forøgelse af calciumabsorption fra tarmen
DE60220422D1 (de) Substituierte pyrazoloverbindungen zur behandlung von entzündungen
EP1432310A4 (en) METHOD FOR TREATING CHRONIC CARDIAC INSUFFICIENCY AND / OR HIGH-CHOLESTEROL ACID RATES WITH 3,5-DITODYTHYROPROPIONIC ACID AND PROCESS FOR PREPARING THE SAME
EA200400482A1 (ru) Кератиноциты, пригодные для применения в качестве биологически активной субстанции при лечении ран
FI930634A0 (fi) Benzimidazolderivat, foerfarande foer framstaellning daerav och deras anvaendning
DE60021873D1 (de) Zubereitung zur prophylaxe oder behandlung der demenz-erkrankung enthaltend ein hydroxyzimtsäurederivat oder einen extrakt einer pflanze der gattung angelica, der diese säure enthält.
ATE338036T1 (de) Zur behandlung hyperproliferativer erkrankungen geeignete benzofuran- und benzothiophenderivate
DK0645141T3 (da) Anvendelse af surt vand til fremstilling af et medikament til behandling af hudsygdomme hos husdyr
SV2002000290A (es) Eteres de dicarboxilato de calcio, metodos para su preparacion y tratamiento de las enfermedades vasculares y diabetes con los mismos ref. pc5953-01-ca/20132/bb
ES2184097T3 (es) Nuevos compuestos.
DE60044160D1 (de) Behandlung von Inkontinenz
ATE192923T1 (de) Verwendung von boswelliasäure zur behandlung von hirntumoren
ITMI931700A1 (it) Procedimento per la potabilizzazione delle acque destinate al consumo umano
MX26167A (es) Derivados de acido piridil-benzoico para el tratamiento de enfermedades relacionadas con lecotrino.
DE60138371D1 (de) PROSTAGLANDINE zur Behandlung von Lichtstrahlung erzeugten Augenerkrankungen wie Photoretinitis
PL376835A1 (pl) Sposób pobudzania wzrostu włosów z użyciem benzopiranów
ATE345123T1 (de) Behandlung von angiogenesebezogenen krankheiten mit benzoyl phenylessigsäure derivaten

Legal Events

Date Code Title Description
FD Lapse